Search

everythinglearnresearchcommunity

for

Search:↓

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

A new method to make finasteride for hair loss treatment was developed.

A new compound that could treat various androgen-related conditions was created and analyzed.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Two impurities in finasteride were identified and characterized as cyclohexyl and phenyl analogs.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A new method to make Finasteride is more cost-effective and yields 16%.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Potential new drugs for treating PCOS were identified.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Finasteride's molecular and crystal structures help develop new drug formulations.